Potential Cardio-Protective Agents: A Resveratrol Review (2000-2019)

With a 2030 projection of 23.6 million deaths per year, the prevalence and severity cardiovascular disease are astoundingly high. Thus, there is definitive need for identification novel compounds with potential to prevent or treat associated states. Moreover, also an ever-increasing drug delivery systems (DDS) that cope poor ranging physiochemical properties therapeutic achieve clinical effect. The usage resveratrol (RES) growing area interest innumerate pieces research, evidencing drug’s efficacy. This is, however, marred; its notably (namely water solubility) limit use oral delivery. RES analogues, potentially possess superior characteristics offering remedy aforementioned drawback. However, particulate based DDS equally able offer property amelioration targeting. review offers extensive examination into role as cardioprotective agent. suitability analogues nanotechnology in overcoming physicochemical boundaries, particularly through development nanoparticulate formulations, will be discussed detail.